FDA Reports Current Drgu Shortage for Teva Parenteral Medicines, Inc.'s Zanosar (Streptozocin) Injection

San Francisco, Calif., -- The FDA reports a current drug shortages for Zanosar (Streptozocin) Injection due to manufactering delays. The drug is manufactered by Teva Parenteral Medicines, Inc.

Please call 1-888-TevaUSA for more information.

Visit the FDA. for additional information on this and other current drug shortages.

Contact Suvarna Bhatt at sbhatt@biospace.com.

Back to news